Back pain prevention in multiple myeloma using a spinal brace (MAPP)

  • Research type

    Research Study

  • Full title

    Back pain prevention in multiple myeloma using an external spinal brace - a feasibility study

  • IRAS ID

    193475

  • Contact name

    Sandeep Konduru

  • Contact email

    sandeep.konduru@uhns.nhs.uk

  • Sponsor organisation

    University Hospitals of North Midlands NHS Trust

  • ISRCTN Number

    ISRCTN11368725

  • Duration of Study in the UK

    2 years, 0 months, 0 days

  • Research summary

    Myeloma is a blood cancer that affects several bones, mostly the spine. Around one person in 120-150 is at risk of developing myeloma. Current treatment can control the cancer and symptoms. However, it does not offer a cure and has little effect on preventing back pain, disability, spinal deformity - which may need difficult spinal surgery. \n\nAn audit of our own practice suggests using an external spinal brace during treatment can: \n•\treduce back pain intensity \n•\thelp prevent disability \n•\tminimise the risk of spinal deformity\n•\treduce NHS costs\n\nManaging such back pain with a brace has not been tested and is not routine practice in other centres in the UK. Therefore, this feasibility study will determine if a randomised controlled trial (RCT) of the brace in multiple centres is possible. We will use the information from this feasibility study to plan a subsequent RCT. The RCT will assess whether using a brace can minimise back pain and disability compared to standard medical treatment alone. \n\nIn this feasibility study, 80 consenting myeloma patients will be randomly allocated to receive either standard medical treatment (chemotherapy, radiotherapy, pain killing medication) alone or a brace with standard medical treatment. Patients will be evaluated at baseline, 6 weeks and 3 months to determine the number of patients required for the full trial. Information will be collected to inform a list of requirements a centre needs to have in place to perform an RCT.\n\nPatient and public involvement (PPI) has shaped the design of this study, including suggesting disability as an outcome.

  • REC name

    East Midlands - Leicester South Research Ethics Committee

  • REC reference

    16/EM/0166

  • Date of REC Opinion

    27 May 2016

  • REC opinion

    Further Information Favourable Opinion